Clinical Trial Update: Sapu003 in Advanced mTOR-sensitive Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update for Sapu003 in advanced mTOR-sensitive solid tumors, currently recruiting across multiple indications including metastatic breast cancer, r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hepatocellular Carcinoma
• Neuroendocrine Tumor
• Renal Cell Carcinoma
• Tuberous Sclerosis Complex

Drugs mentioned

• Sapu003

Snippet

Sponsor: SAPU NANO (US) LLC | Conditions: Breast Cancer Metastatic, Renal Cell Carcinoma (RCC) | Phase 1 | Status: RECRUITING